NTLA R&D to Revenue
Intellia Therapeutics Inc · R&D to Revenue
NTLA R&D to Revenue
Latest reported574.63%period ending
NTLA FY R&D/Revenue (0.00% → 574.63%)
Latest values, visible window
High-resolution chart · PNG
NTLA r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 574.6346% | |
| 805.6931% | |
| 1,199.3632% | |
| 805.7769% | |
| 695.2682% | |
| 259.351% | |
| 251.5208% | |
| 292.814% | |
| 259.0152% | |
| 193.2156% | |
| 184.8114% | |
| 0% |